General · 7 July 2026
Nasal vaccines could stop airborne infections earlier by boosting airway immunity
New research into lung-resident memory B cells shows future vaccines need to protect airways, not just the bloodstream, where respiratory infections begin. Scientists reviewed over 130 studies, highlighting diverse memory B cells that act as a front-line defence in the respiratory tract. These findings could help in the development of new nasal vaccines that are better at controlling infections and lowering the spread of airborne pathogens.
Reported by News-Medical · How we write briefs